Company Filing History:
2 out of 5 
1 out of 4,456 
Years Active: 2014-2015
Title: Moorthy Sitharamaiah Suriyanarayana Palanki: Innovator in Anti-Diabetic Compounds
Introduction
Moorthy Sitharamaiah Suriyanarayana Palanki is a notable inventor based in Encinitas, California. He has made significant contributions to the field of diabetes treatment through his innovative research and patented inventions. With a total of two patents to his name, Palanki is recognized for his work in developing anti-diabetic compounds.
Latest Patents
Palanki's latest patents focus on novel anti-diabetic compounds. The first patent presents a composition with the formula: [FGF21-1Linker]-[Ab]-[2-Linker-Ex4]. This invention includes an FGF21 homologue and an Exendin4 homologue, along with an aldolase catalytic antibody. The composition aims to provide methods for preventing or treating diabetes and related conditions. The second patent involves FGF21 molecules covalently attached to an antibody via a linker, also targeting diabetes treatment. Both patents highlight various uses of these compounds in combating diabetes.
Career Highlights
Throughout his career, Palanki has worked with prominent companies in the pharmaceutical industry. He has been associated with Covx Technologies Ireland Limited and Pfizer Corporation, where he contributed to research and development in the field of diabetes.
Collaborations
Palanki has collaborated with notable professionals in his field, including Nancy Jane Levin and Tapan Kanti Das. These collaborations have likely enhanced his research and innovation efforts.
Conclusion
Moorthy Sitharamaiah Suriyanarayana Palanki is a distinguished inventor whose work in anti-diabetic compounds has the potential to significantly impact diabetes treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes.